Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit

Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit

SINGAPORE, March 12, 2026 /PRNewswire/ -- Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles River Laboratories ("Charles River"), a global contract...

Mace Consult Launches as a Standalone Company to Set New Standards for Program and Project Delivery

Mace Consult Launches as a Standalone Company to Set New Standards for Program and Project Delivery

Majority investment from Goldman Sachs Alternatives in Mace Consult completed, creating a new and independent leading program and project management services provider Begins new phase as client-centric partner, providing seamless collaboration and...

TDK opens its fifth regional headquarters in Asia-Pacific with a new business entity in India

TDK opens its fifth regional headquarters in Asia-Pacific with a new business entity in India

TDK establishes Asia-Pacific Regional Headquarters (APAC RHQ) in India, effective 1 April 2026 APAC RHQ will be operated by TDK Asia-Pacific Pvt. Ltd., a new legal entity to be established in India, and TDK Singapore Pte. Ltd., forming a dual-city...

Discovery linking gut bacteria to cancer treatment wins the Bial Award in Biomedicine and earns €350,000 prize

Discovery linking gut bacteria to cancer treatment wins the Bial Award in Biomedicine and earns €350,000 prize

A study published in Science reveals that a healthy gut microbiota can enhance the efficacy of immunotherapy used to treat cancer, while antibiotics may impair its effect by reducing intestinal microbiota diversity. PORTO, Portugal, Feb. 25, 2026...

Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard

Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard

TIANJIN, China, Jan. 26, 2026 /PRNewswire/ -- In a landmark move for the cell therapy industry, a Device Master File (DMF) describing the first dedicated quality control standard for Mesenchymal Stromal Cells (MSCs) was accepted by the U.S. Food and...

NX Group Establishes NX East Asia as Regional Headquarters Company to Pursue Global Growth Originating from East Asia

NX Group Establishes NX East Asia as Regional Headquarters Company to Pursue Global Growth Originating from East Asia

TOKYO, Jan. 13, 2026 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC. has established a new regional headquarters company -- Nippon Express East Asia Co., Ltd. (hereinafter "NX East Asia") -- effective January 1, 2026, with the aim of expanding...

Affinidi Launches Pilot to Enable Cross-Border Trade as Reusable Credential Ecosystem Launches for Talent Corridors

Affinidi Launches Pilot to Enable Cross-Border Trade as Reusable Credential Ecosystem Launches for Talent Corridors

Pilot programme transforms employment verification from weeks to minutes, starting with the Singapore-India corridor. SINGAPORE, Dec. 17, 2025 /PRNewswire/ -- Affinidi has launched a pilot to advance global and regional interoperability, enabling...

Korean Water-Tech Innovator ECOPEACE Establishes Singapore JV to Tackle Regional Water Pollution with AI Robotics

Korean Water-Tech Innovator ECOPEACE Establishes Singapore JV to Tackle Regional Water Pollution with AI Robotics

SINGAPORE, Dec. 17, 2025 /PRNewswire/ -- ECOPEACE, a South Korean leader in AI- and robotics-based water-quality management, today announced the formation of a new joint venture in Singapore as the cornerstone of its expansion across Southeast Asia...

Leading South Korean Printer TARAtps Acquires Chicago Offset, Establishes TARA USA

Leading South Korean Printer TARAtps Acquires Chicago Offset, Establishes TARA USA

With the US printing firm now a wholly owned subsidiary of TARAtps, the newly established TARA USA is set to strengthen value for North American customers with a dual-production system spanning South Korea and the US. CHICAGO, Dec. 11, 2025...

Zymedi Announces "rapaprutug" as the International Nonproprietary Name (INN) for ZMA001

Zymedi Announces "rapaprutug" as the International Nonproprietary Name (INN) for ZMA001

INCHEON, South Korea, Dec. 8, 2025 /PRNewswire/ -- Zymedi (CEO Sunghoon Kim) announced that the World Health Organization (WHO) has assigned rapaprutug as the International Nonproprietary Name (INN) for the company's first-in-class antibody therapy...

  • 1
  • 2
  • 3
  • 4
  • 5
  • menu
    menu